254 results on '"Vitamin D Deficiency epidemiology"'
Search Results
2. Role of Vitamin D in Oral Lichen Planus: A Case Control Study.
- Author
-
García-Pola M and Rodríguez-Fonseca L
- Subjects
- Humans, Female, Male, Middle Aged, Case-Control Studies, Aged, Adult, Logistic Models, Risk Factors, Prevalence, Comorbidity, Lichen Planus, Oral blood, Vitamin D Deficiency blood, Vitamin D Deficiency complications, Vitamin D Deficiency epidemiology, Vitamin D blood, Dietary Supplements
- Abstract
Background: It has been reported that vitamin D deficiency may be associated with the development of oral lichen planus (OLP). Given the high prevalence of vitamin D deficiency in many countries, we sought to determine whether it constitutes a comorbidity of OLP., Methods: One hundred and twenty patients clinically and histologically diagnosed with OLP were evaluated for their serum vitamin D levels. The results were compared to results from a control series of the same number of subjects matched for age and sex., Results: Vitamin D deficiency was diagnosed in 45% ( n = 54) of OLP patients and in 26.7% ( n = 32) of the control group. Vitamin D supplements were being taken by 32 (26.7%) OLP patients and 15 (12.5%) subjects in the control group. A multivariate logistic regression model showed that OLP was associated with vitamin D deficiency [OR: 2.24 (1.28-3.98, p = 0.005)] and vitamin D supplementation [OR: 2.51 (1.25-5.22, p = 0.011)], even after controlling for confounding variables such as sex, age ≤60>, tobacco, and alcohol., Conclusion: The association between OLP patients and vitamin D deficiency or vitamin D supplementation suggests that further research might explore the benefits of vitamin D supplements in managing OLP patients.
- Published
- 2024
- Full Text
- View/download PDF
3. Optimisation of vitamin D status in global populations.
- Author
-
Harvey NC, Ward KA, Agnusdei D, Binkley N, Biver E, Campusano C, Cavalier E, Clark P, Diaz-Curiel M, Fuleihan GE, Khashayar P, Lane NE, Messina OD, Mithal A, Rizzoli R, Sempos C, and Dawson-Hughes B
- Subjects
- Humans, Food, Fortified, Mass Screening methods, Bone Density Conservation Agents therapeutic use, Vitamin D Deficiency complications, Vitamin D Deficiency epidemiology, Vitamin D Deficiency drug therapy, Vitamin D blood, Vitamin D analogs & derivatives, Vitamin D therapeutic use, Dietary Supplements, Global Health
- Abstract
Vitamin D is important for musculoskeletal health. Concentrations of 25-hydroxyvitamin D, the most commonly measured metabolite, vary markedly around the world and are influenced by many factors including sun exposure, skin pigmentation, covering, season and supplement use. Whilst overt vitamin D deficiency with biochemical consequences presents an increased risk of severe sequelae such as rickets, osteomalacia or cardiomyopathy and usually warrants prompt replacement treatment, the role of vitamin D supplementation in the population presents a different set of considerations. Here the issue is to keep, on average, the population at a level whereby the risk of adverse health outcomes in the population is minimised. This position paper, which complements recently published work from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, addresses key considerations regarding vitamin D assessment and intervention from the population perspective. This position paper, on behalf of the International Osteoporosis Foundation Vitamin D Working Group, summarises the burden and possible amelioration of vitamin D deficiency in global populations. It addresses key issues including screening, supplementation and food fortification., (© 2024. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.)
- Published
- 2024
- Full Text
- View/download PDF
4. Association of vitamin D intake during pregnancy with small vulnerable newborns: a population-based cohort study.
- Author
-
Wang S, Villagrán Escobar GM, Chen Z, Li X, Xiong G, Yang X, Shen J, and Hao L
- Subjects
- Humans, Female, Pregnancy, Infant, Newborn, Adult, Cohort Studies, Vitamin D Deficiency epidemiology, Premature Birth, Male, China, Infant, Low Birth Weight, Young Adult, Prospective Studies, Pregnancy Complications, Vitamin D administration & dosage, Vitamin D blood, Infant, Small for Gestational Age, Dietary Supplements
- Abstract
Maternal vitamin D deficiency is common worldwide and has a significant impact on newborns. However, whether vitamin D intake during pregnancy is related to small vulnerable newborns (SVN) has not been confirmed. Thus, we sought to examine the relationship between maternal vitamin D intake, including vitamin D supplementation and dietary intake, and the risk of SVN. A total of 2980 Chinese mother-infant pairs were included in this study. Information on vitamin D supplementation and dietary intake was prospectively collected through face-to-face interviews. The outcomes assessed included low birth weight (LBW), preterm birth (PTB), small for gestational age (SGA), and SVN (having LBW, PTB, or SGA). Logistic regression models were used to evaluate the association of vitamin D intake with different types of SVN, and a restricted cubic spline function was modeled to explore their dose-response associations. Compared to the lowest total vitamin D intake in the first trimester, the highest total vitamin D intake was associated with a 50.0% decrease in the SGA risk (OR: 0.50, 95% CI: 0.26, 0.96) and a 41.0% decrease in the SVN risk (OR: 0.59, 95% CI: 0.36, 0.95). Similar protective results were observed between vitamin D supplementation in the first trimester and SGA and SVN risks. Moreover, a significant L-shaped relationship was identified for total vitamin D intake, vitamin D supplementation, and dietary intake with the risk of different types of SVN. In conclusion, higher total vitamin D intake and supplementation in the first trimester were associated with a reduced risk of SGA and SVN.
- Published
- 2024
- Full Text
- View/download PDF
5. Rise in Serum 25-Hydroxyvitamin D Levels during the COVID-19 Pandemic.
- Author
-
Durden W, Ezaldin S, Amos J, Kemper S, and Campbell J
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Adult, Pandemics, Aged, COVID-19 blood, COVID-19 epidemiology, Vitamin D blood, Vitamin D analogs & derivatives, Dietary Supplements, SARS-CoV-2, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Vitamin D Deficiency drug therapy
- Abstract
With the emergence of the COVID-19 pandemic, the absence of established evidence-based treatment protocols led healthcare professionals and the public to explore experimental treatments, including high doses of vitamin D supplements. This study aimed to assess changes in serum 25-hydroxyvitamin D levels during the pandemic, employing a retrospective cohort analysis of data from Charleston Area Medical Center (CAMC). The study analyzed serum 25-hydroxyvitamin D levels in a cohort of 35,556 patients treated at CAMC in 2019, a representative pre-pandemic period, to 2021, a representative pandemic period. Our findings revealed a significant increase in mean serum 25-hydroxyvitamin D levels as compared with 2019 (37 ± 21 vs. 31 ± 15 ng/mL, p ≤ 0.001). Additionally, in 2021, there were significantly more patients exhibiting serum levels in the highest quintiles, specifically >100 ng/mL (1.6% vs. 0.2%), 75-100 ng/mL (4.6% vs. 1.2%), and 50-75 ng/mL (16.0% vs. 8.4%), p ≤ 0.001. This upsurge suggests increased intake of vitamin D supplements, potentially fueled by widespread discussions that were taking place largely on the internet regarding the efficacy of vitamin D against COVID-19. Our findings underscore the critical need for evidence-based public health messaging, especially during health crises, to prevent unnecessary health risks and ensure patient safety.
- Published
- 2024
- Full Text
- View/download PDF
6. Maternal Circulating Vitamin D Level, Targeted Supplementation, and Perinatal Outcomes in Twin Pregnancy.
- Author
-
Roero S, Ingala A, Arduino S, Folino Gallo M, Arese A, Ferrando I, Bossotti C, and Revelli A
- Subjects
- Humans, Female, Pregnancy, Adult, Hypertension, Pregnancy-Induced blood, Hypertension, Pregnancy-Induced epidemiology, Pregnancy Trimester, First blood, Pregnancy Complications blood, Vitamin D blood, Vitamin D administration & dosage, Vitamin D analogs & derivatives, Pregnancy, Twin blood, Dietary Supplements, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Pregnancy Outcome
- Abstract
Background: Vitamin D deficiency is associated with several obstetric complications in singleton pregnancy. The aim of this study was to assess whether vitamin D levels affect the outcomes of twin pregnancy and if targeted supplementation can improve perinatal outcomes., Methods: The serum vitamin D levels of 143 women with twin pregnancies were measured during their first trimester. Those with insufficient (10-30 ng/mL; IL group) or severely deficient (<10 ng/mL, DL group) vitamin D levels were supplemented. In the third trimester, vitamin D levels were reassessed. Perinatal outcomes of the IL and DL groups were compared with those of patients with sufficient levels (>30 ng/mL, SL group) since the beginning of pregnancy., Results: Women in the IL and DL groups had a higher incidence of hypertensive disorders of pregnancy (HDP) compared to the SL group (24.8% and 27.8% vs. 12.5%, p = 0.045): OR = 1.58 for the IL group and 1.94 for the DL group compared to the SL group. In patients whose vitamin D levels were restored after supplementation, HDP incidence was lower than in patients who remained in the IL or DL groups (23.4% vs. 27.3%) but higher than those who were always in the SL group (12.5%)., Conclusions: Insufficient or severely deficient levels of vitamin D in the first trimester are associated with an increased risk of HDP in twin pregnancy. The beneficial effect of targeted vitamin D supplementation in reducing HDP seems limited.
- Published
- 2024
- Full Text
- View/download PDF
7. Correlation of Maternal Vitamin D Status in Early Pregnancy and Vitamin D Supplementation during Pregnancy with Atopic Dermatitis in Infants: A Prospective Birth Cohort Study.
- Author
-
Zhang Q, Yang D, Shen Q, Li W, Li R, Tang Y, Lei Z, Li B, Ding X, Ni M, Chen Z, Lin Z, Cheng C, Yao D, Hu Y, Liu X, Zhao J, Chen H, and Liu Z
- Subjects
- Humans, Female, Pregnancy, Prospective Studies, Adult, Infant, China epidemiology, Infant, Newborn, Birth Cohort, Maternal Nutritional Physiological Phenomena, Pregnancy Complications blood, Pregnancy Complications epidemiology, Risk Factors, Male, Incidence, Dermatitis, Atopic epidemiology, Dermatitis, Atopic blood, Vitamin D analogs & derivatives, Vitamin D blood, Dietary Supplements, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Pregnancy Trimester, First blood
- Abstract
Objective: This study aimed to investigate the association of maternal first-trimester vitamin D levels and vitamin D supplementation during pregnancy with infant atopic dermatitis (AD) and to determine the effect of variables such as mode of conception on the association., Methods: This study was based on the Shanghai sub-cohort of the International Birth Cohort of China. A total of 4051 woman-infant pairs with singleton pregnancies were recruited. Vitamin D deficiency and insufficiency were defined as serum 25-hydroxyvitamin D concentrations of 25 and 50 nmol/L, respectively. AD in infants was assessed during the first six months using a standardized questionnaire based on the British Working Party criteria. Modified Poisson regression estimated the association between maternal vitamin D status and infant AD., Results: The risk of AD in infants was higher in women with deficient 25-hydroxyvitamin D levels in the first trimester (RR: 1.77, 95% CI: 1.41-2.23). This increased risk was seen in naturally conceived pregnancies, but not in those conceived using assisted reproductive technology (ART). The incidence of AD decreased in infants of mothers who took multi-vitamin (RR: 0.79, 95% CI: 0.67-1.98) and vitamin D supplements (RR: 0.51, 95% CI: 0.37-0.71) compared to those whose mothers did not take any supplements. Maternal vitamin D deficiency had varying effects on AD risk based on passive smoking exposure and breastfeeding patterns., Conclusions: Our findings highlight the importance of monitoring and supplementing vitamin D during pregnancy, especially in specific maternal populations, to reduce the risk of AD in offspring.
- Published
- 2024
- Full Text
- View/download PDF
8. Postoperative Vitamin D Surveillance and Supplementation in Revision Total Knee Arthroplasty Patients: A Retrospective Cohort Analysis.
- Author
-
Duggan JL, Fitz W, Lange JK, Shah VM, Olsen A, Iorio R, and Chen AF
- Subjects
- Humans, Retrospective Studies, Male, Female, Aged, Middle Aged, Postoperative Complications epidemiology, Postoperative Complications prevention & control, Aged, 80 and over, Incidence, Arthroplasty, Replacement, Knee, Vitamin D Deficiency epidemiology, Reoperation statistics & numerical data, Vitamin D blood, Vitamin D administration & dosage, Dietary Supplements
- Abstract
This study was a retrospective cohort analysis of 20 patients who underwent 23 revision total knee arthroplasty procedures in a single geographic region of the United States from January 2015 to February 2023. We analyzed their 25-OH vitamin D levels preoperatively and postoperatively at 1 month, 3 months, 6 months, 1 year, and 2 years. We categorized their supplementation regimens by dose: none, low dose (1000 IU and below), medium dose (1001-5000 IU), and high dose (>5000 IU). We found that there was a high incidence of vitamin D deficiency in this patient population., Competing Interests: Disclosure The authors have no commercial of financial conflicts of interest to disclose in the subject matter of this study., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Vitamin D supplementation during pregnancy and the role of maternal prenatal depression.
- Author
-
Lv B, Zheng A, and Han L
- Subjects
- Humans, Female, Pregnancy, Retrospective Studies, Adult, China epidemiology, Incidence, Vitamins administration & dosage, Vitamins therapeutic use, Prenatal Care methods, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Vitamin D Deficiency drug therapy, Vitamin D Deficiency complications, Vitamin D blood, Vitamin D administration & dosage, Dietary Supplements, Depression epidemiology, Pregnancy Complications psychology, Pregnancy Complications drug therapy
- Abstract
Background: The current study sought to investigate the correlation between vitamin D supplementation in pregnant women with vitamin D deficiency in early pregnancy and the incidence of prenatal depression prior to delivery., Methods: This is a retrospective, single-center study that was conducted at a tertiary hospital in Chengdu, China. We conducted an analysis on pregnant women who were initially diagnosed with vitamin D deficiency at 12-14 weeks of gestation. After starting vitamin D supplementation at a dose of 800 IU daily from 14 weeks onwards, we measured both their vitamin D concentration and depression scores again during median gestational week 39 prior to delivery., Results: The study cohort comprised 1365 women who had been diagnosed with vitamin D deficiency at 12-14 weeks of gestation between November 1st, 2021 to November 1st, 2022. 537 pairs were matched based on a propensity score to control for other confounding factors. After propensity score matching, the baseline vitamin D levels were made consistent between the groups (P = 0.512). The incidence of depression in patients in vitamin D deficiency group following vitamin D supplementation was significantly higher than insufficiency group and reached statistical significance (P < 0.001). Additionally, we observed that serum 25-(OH) D concentration achieving insufficiency status after supplementation was 59.12%., Conclusion: Our study indicates that daily supplementation of 800IU of vitamin D can improve the depressive symptoms of individuals who are vitamin D deficiency during early pregnancy but achieve vitamin D insufficiency after supplementation during prenatal period., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
10. Does Vitamin D3 Supplementation Improve Depression Scores among Rural Adolescents? A Randomized Controlled Trial.
- Author
-
Satyanarayana PT, Suryanarayana R, Yesupatham ST, Varadapuram Ramalingareddy SR, and Gopalli NA
- Subjects
- Humans, Adolescent, Male, Female, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Vitamin D administration & dosage, India epidemiology, Dietary Supplements, Depression epidemiology, Cholecalciferol administration & dosage, Rural Population
- Abstract
Background: Contemporary evidence has been established demonstrating that stunted vitamin D levels are associated with depression, poor mood, and other mental disorders. Individuals with normal vitamin D levels have a much lower probability of developing depression. Improving vitamin D levels by supplementation has shown betterment in depressive patients among different age groups. The objective of this study was to assess the effect of vitamin D supplementation on depression scores among rural adolescents., Material and Methods: This study was a cluster randomized controlled trial carried out for a period of 3 years among adolescents from rural Kolar. The sample size was calculated based on previous research and was determined to be 150 for each group. The intervention arm received 2250 IU of vitamin D, and the control arm received a lower dose of 250 IU of vitamin D for 9 weeks. To assess sociodemographic status, a pretested, semi-structured questionnaire was used, and, to assess depression, the Beck Depression Inventory (BDI-II) was used. A baseline assessment was carried out for vitamin D status and depression status, followed by a post-intervention assessment. From the start of the trial, the participants were contacted every week by the pediatric team to investigate any side effects., Results: Out of 235 school students in the vitamin D supplementation arm, 129 (54.9%) belonged to the 15 years age group, 124 (52.8%) were boys, and 187 (79.6%) belonged to a nuclear family. Out of 216 school students in the calcium supplementation arm, 143 (66.2%) belonged to the 15 years age group, 116 (53.7%) were girls, and 136 (63%) belonged to a nuclear family. By comparing Beck depression scores before and after the intervention, it was found that the vitamin D intervention arm showed a statistically significant reduction in Beck depression scores., Conclusions: The present study showed that vitamin D supplementation reduced depression scores, showing some evidence that nutritional interventions for mental health issues such as depression are an excellent option. Vitamin D supplementation in schools can have numerous beneficiary effects on health while mutually benefiting mental health.
- Published
- 2024
- Full Text
- View/download PDF
11. Exploring the Preventive Potential of Vitamin D against Respiratory Infections in Preschool-Age Children: A Cross-Sectional Study.
- Author
-
Sarau OS, Rachabattuni HC, Gadde ST, Daruvuri SP, Marusca LM, Horhat FG, Fildan AP, Tanase E, Prodan-Barbulescu C, and Horhat DI
- Subjects
- Humans, Child, Preschool, Cross-Sectional Studies, Male, Female, Incidence, Romania epidemiology, Infant, Recurrence, Respiratory Tract Infections prevention & control, Respiratory Tract Infections epidemiology, Vitamin D blood, Vitamin D analogs & derivatives, Vitamin D administration & dosage, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Dietary Supplements
- Abstract
Recent studies hypothesized that vitamin D supplementation and subsequent higher 25(OH)D serum levels could protect against respiratory infections in children. This cross-sectional study, conducted from May 2022 to December 2023 in Timisoara, Romania, aimed to evaluate the potential influence of vitamin D supplementation on the incidence of respiratory infections among preschool-age children. This study examined 215 children over 18 months who were split into a group of patients with recurrent respiratory infections ( n = 141) and another group of patients with only one respiratory tract infection in the past 12 months ( n = 74). Patients were evaluated based on their serum vitamin D levels 25(OH)D, demographic characteristics, and health outcomes. The study identified that preschool-age children with recurrent infections had significantly lower mean vitamin D concentrations (24.5 ng/mL) compared to the control group (29.7 ng/mL, p < 0.001). Additionally, a higher proportion of vitamin D deficiency was observed among children with recurrent infections in the past 12 months. Notably, vitamin D supplementation above 600 IU/week significantly reduced the likelihood of respiratory infections, evidenced by an odds ratio of 0.523 ( p < 0.001), indicating that preschool-age children receiving a dose of vitamin D higher than 600 IU/week were about half as likely to experience respiratory infections compared to those who did not. Furthermore, no significant associations were found between sun exposure, daily sunscreen use, and the incidence of respiratory infections. Conclusively, this study underscores the potential role of vitamin D in helping the immune system against respiratory infections in preschool-age children. The observed protective effect of vitamin D supplementation suggests a potential public health strategy to mitigate the incidence of respiratory infections in preschool children on top of the already known benefits.
- Published
- 2024
- Full Text
- View/download PDF
12. A Study of Vitamin D Status and Its Influencing Factors among Pregnant Women in Szeged, Hungary: A Secondary Outcome of a Case-Control Study.
- Author
-
Polanek E, Sisák A, Molnár R, Máté Z, Horváth E, Németh G, Orvos H, Paulik E, and Szabó A
- Subjects
- Humans, Female, Pregnancy, Hungary, Case-Control Studies, Adult, Retrospective Studies, Maternal Nutritional Physiological Phenomena, Pregnancy Complications blood, Pregnancy Complications epidemiology, Young Adult, Prenatal Care, Pregnant Women, Surveys and Questionnaires, Vitamin D blood, Vitamin D administration & dosage, Dietary Supplements, Nutritional Status, Vitamin D Deficiency epidemiology, Vitamin D Deficiency blood
- Abstract
Adequate vitamin D (VD) intake during pregnancy is needed for fetal development and maternal health maintenance. However, while there is no doubt regarding its importance, there is not a unified recommendation regarding adequate intake. The main aim of our study was to measure the VD serum level of studied women, together with its potential influencing factors: demographic (i.e., age, level of education, relationship status and type of residence), conception and pregnancy related factors. Results are based on secondary data analyses of a retrospective case-control study of 100 preterm and 200 term pregnancies, where case and control groups were analyzed together. Data collection was based on a self-administered questionnaire, health documentation, and maternal serum VD laboratory tests. VD intake was evaluated by diet and dietary supplement consumption. According to our results, 68.1% of women took some kind of prenatal vitamin, and only 25.9% of them knew about its VD content. Only 12.1% of included women reached the optimal, 75 nmol/L serum VD level. Higher maternal serum levels were associated with early pregnancy care visits ( p = 0.001), assisted reproductive therapy ( p = 0.028) and advice from gynecologists ( p = 0.049). A correlation was found between VD intake and serum levels ( p < 0.001). Despite the compulsory pregnancy counselling in Hungary, health consciousness, VD intake and serum levels remain below the recommendations. The role of healthcare professionals is crucial during pregnancy regarding micronutrients intake and the appropriate supplementation dose.
- Published
- 2024
- Full Text
- View/download PDF
13. Vitamin D supplements and future fracture risk among Mongolian schoolchildren.
- Author
-
Ma N, Cui X, and Niu W
- Subjects
- Humans, Child, Mongolia epidemiology, Female, Male, Adolescent, Risk Factors, Vitamin D Deficiency epidemiology, Vitamin D, Dietary Supplements, Fractures, Bone epidemiology, Fractures, Bone prevention & control
- Abstract
Competing Interests: We declare no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
14. Vitamin D and Menopause.
- Author
-
Sharma M and Kalra S
- Subjects
- Female, Humans, Vitamins therapeutic use, Dietary Supplements, Menopause drug effects, Menopause physiology, Vitamin D, Vitamin D Deficiency epidemiology, Vitamin D Deficiency complications
- Abstract
Menopause is the transition period in female life cycle. Resultant hormonal changes lead to adverse health effects. Women may seek treatment due to significant impairment in quality of life. Vitamin D deficiency is a globally prevalent problem. Vitamin D deficiency in menopausal women may aggravate the adverse health risks associated with menopause. In this article, the authors discuss endocrinology and clinical features of menopause, Vitamin D and its links with menopause, and the potential role of Vitamin D supplementation to combat detrimental multi-organ system effects of menopause.
- Published
- 2024
- Full Text
- View/download PDF
15. Monitoring the utilization and effectiveness of Iron and Vitamin D supplementations program and its predictive factors in high schools' girls in Qom, Iran.
- Author
-
Ahangari R, Mohammadbeigi A, Miraj S, Rajabi N, and Mohammadpour R
- Subjects
- Humans, Female, Adolescent, Iran, Cross-Sectional Studies, Child, Vitamin D Deficiency epidemiology, Schools, Cholecalciferol administration & dosage, Cholecalciferol therapeutic use, Vitamin D administration & dosage, Iron administration & dosage, Surveys and Questionnaires, Dietary Supplements
- Abstract
Background: Iron and Vitamin D3 deficiency is one of the major global health problems in teenagers and adolescent population. This study was aimed to monitor the utilization and predictive factors of Iron and Vitamin D Supplementations Program (IVDSP) in high schools' girls., Methods: In a cross sectional study, the pattern of Iron and D3 consumption based on IVDSP on 400 high schools' girl in Qom, Iran assesses. Data collection was used by a reliable and standard researcher based questionnaire and daily, weekly, monthly and seasonally consumption of complementary minerals in schools were gathered. Data analysis conducted using SPSS version 20 (SPSS Inc., Chicago, IL, USA) by chi square, independent t-test and multivariate logistic regression., Results: The mean age of subjects was 15.14 ± 1.52 years and ranged from 12 to 18 years old. The total weekly prevalence of D3 and Iron consumption in high schools' girls was calculated 36.73% and the weekly prevalence of Iron and monthly prevalence of Vitamin D3 consumption was 33.75% and 40.5%, respectively. The most common causes of non-consumption were bad taste 49.31%, Iranian made drug 20.27%, drug sensitivity 19.82% and drug interaction 10.60%, respectively., Conclusions: The inadequate and incomplete rate of IVDSP in Qom was high and more than 60% of distributed supplementations have been wasted. Results showed that students who were participated in educational orientation classes were more successful and eager in Iron and Vitamin D3 consumption. Therefore, more educational explanatory interventions for both students and her parents recommended to increase the efficiency of the program., Competing Interests: None declared., (©2024 Pacini Editore SRL, Pisa, Italy.)
- Published
- 2024
- Full Text
- View/download PDF
16. Prospective cohort study of vitamin D deficiency in pregnancy: Prevalence and limited effectiveness of 1000 IU vitamin D supplementation.
- Author
-
Abdelmageed RM, Hussein SMM, Anamangadan SM, Abdullah RWM, Rauf L, AlFehaidi AS, and Hamed E
- Subjects
- Female, Humans, Pregnancy, Prevalence, Prospective Studies, Vitamin D therapeutic use, Vitamins therapeutic use, Dietary Supplements, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control
- Abstract
Background: Vitamin D deficiency is highly prevalent worldwide among pregnant women. Although vitamin D supplementation is effective in improving vitamin D status, the safety and optimal dosing of vitamin D supplementation during pregnancy remain less well understood., Objective: This study aimed to investigate the prevalence of vitamin D deficiency among pregnant women and evaluate the effectiveness of vitamin D supplementation in improving vitamin D status during pregnancy., Design: This prospective cohort study assessed the impact of a 16-week daily vitamin D supplementation 1000 IU regimen on vitamin D status among pregnant women., Methods: A total of 365 pregnant women were recruited, and their baseline total circulating 25-hydroxy vitamin D concentrations were measured. Of these, 249 participants completed the study, which involved oral daily supplementation with 1000 IU of vitamin D and a repeat of total circulating 25-hydroxy vitamin D concentrations after 16 weeks., Results: The study found that 57.7% of the participants had vitamin D deficiency, consistent with the rates reported in other studies. However, vitamin D supplementation at a dose of 1000 IU had a small effect size and was not clinically significant. However, 67% of participants with vitamin D deficiency remained deficient; among participants initially with vitamin D insufficiency, 30% became deficient. Moreover, 26.5% of individuals with sufficient vitamin D status at 12 weeks showed insufficient levels by 28 weeks., Conclusion: Vitamin D deficiency is widespread among pregnant women, and vitamin D supplementation at a daily dose of 1000 IU may not adequately address this problem. Although the study has limitations, its results align with previous research and may apply to other populations with a high prevalence of vitamin D deficiency during pregnancy. Further research is necessary to determine the most effective approach for addressing prenatal vitamin D deficiency.
- Published
- 2024
- Full Text
- View/download PDF
17. Vitamin D status and clinical implications in the adult population of Malaysia: a position paper by the Malaysian Vitamin D Special Interest Group.
- Author
-
Lee JK, Chee WS, Foo SH, Lee VK, Sallehuddin H, Khor HM, Arasu K, Mohamad M, Ahmad AR, A/L Puvaneswaran S, Koh KC, Hoo FK, Tan GH, and Mitchell PJ
- Subjects
- Humans, Malaysia epidemiology, Adult, Sunlight, Food, Fortified, Nutritional Status physiology, Vitamin D Deficiency epidemiology, Vitamin D Deficiency blood, Vitamin D Deficiency prevention & control, Vitamin D blood, Vitamin D therapeutic use, Vitamin D analogs & derivatives, Dietary Supplements
- Abstract
Purpose: Vitamin D deficiency and insufficiency is common among populations globally, and in Asia and Malaysia. The purpose of this Position Paper is to propose recommendations for both clinicians and non-clinicians to promote vitamin D sufficiency in Malaysian adults. Formation of a national multisector, multidisciplinary alliance is also proposed to progress initiatives relating to safe sun exposure, adequate vitamin D intake through food fortification, and vitamin D supplementation for high-risk groups., Methods: Literature reviews were undertaken to inform summaries of the following: vitamin D status globally and in Asian and Malaysian populations, vitamin D status among individuals with common medical conditions, and current recommendations to achieve vitamin D sufficiency through sun exposure, food intake and supplementation. Recommendations were based on the findings of the literature reviews, recent European guidance on vitamin D supplementation, the 2018 road map for action on vitamin D in low- and middle-income countries, and research recommendations proposed by the Malaysian Ministry of Health in 2017., Results: Recommendations on assessment of vitamin D in the adult Malaysian population include using serum or plasma 25-hydroxyvitamin D concentration as a biomarker, widespread participation by Malaysian laboratories in the Vitamin D Standardization Program, adoption of the US Endocrine Society definitions of vitamin D deficiency and insufficiency, and development of a comprehensive nationwide vitamin D status study. Specific high-risk groups are identified for vitamin D assessment and recommendations relating to loading doses and ongoing management are also made., Conclusion: This Position Paper provides individual clinicians and national stakeholder organisations with clear recommendations to achieve vitamin D sufficiency in the adult population of Malaysia., (© 2023. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.)
- Published
- 2023
- Full Text
- View/download PDF
18. EMAS position statement: Vitamin D and menopausal health.
- Author
-
Anagnostis P, Livadas S, Goulis DG, Bretz S, Ceausu I, Durmusoglu F, Erkkola R, Fistonic I, Gambacciani M, Geukes M, Hamoda H, Hartley C, Hirschberg AL, Meczekalski B, Mendoza N, Mueck A, Smetnik A, Stute P, van Trotsenburg M, Rees M, and Lambrinoudaki I
- Subjects
- Aged, Female, Humans, Calcium, Calcium, Dietary, Cardiovascular Diseases complications, COVID-19, Diabetes Mellitus, Type 2 complications, Neoplasms complications, Neurodegenerative Diseases, Vitamin D Deficiency complications, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Dietary Supplements, Menopause, Vitamin D
- Abstract
Introduction: There is increasing evidence that vitamin D has widespread tissue effects. In addition to osteoporosis, vitamin D deficiency has been associated with cardiovascular disease, diabetes, cancer, infections and neurodegenerative disease. However, the effect of vitamin D supplementation on non-skeletal outcomes requires clarification, especially in postmenopausal women., Aim: This position statement provides an evidence-based overview of the role of vitamin D in the health of postmenopausal women based on observational and interventional studies., Materials and Methods: Literature review and consensus of expert opinion., Results and Conclusions: Vitamin D status is determined by measuring serum 25-hydroxyvitamin D levels. Concentrations <20 ng/ml (<50 nmol/l) and <10 ng/ml (<25 nmol/l) are considered to constitute vitamin D deficiency and severe deficiency, respectively. Observational data suggest an association between vitamin D deficiency and adverse health outcomes in postmenopausal women, although they cannot establish causality. The evidence from randomized controlled trials concerning vitamin D supplementation is not robust, since many studies did not consider whether people were deficient at baseline. Moreover, high heterogeneity exists in terms of the population studied, vitamin D dosage, calcium co-administration and duration of intervention. Concerning skeletal health, vitamin D deficiency is associated with low bone mass and an increased risk of fractures. Vitamin D supplementation at maintenance doses of 800-2000 IU/day (20-50 μg/day), after repletion of vitamin D status with higher weekly or daily doses, may be of benefit only when co-administered with calcium (1000-1200 mg/day), especially in the elderly populations and those with severe vitamin D deficiency. Concerning cardiovascular disease, vitamin D deficiency is associated with an increased prevalence of cardiovascular risk factors, mainly metabolic syndrome, type 2 diabetes mellitus and dyslipidemia. Vitamin D deficiency, especially its severe form, is associated with an increased risk of cardiovascular events (coronary heart disease, stroke, mortality), independently of traditional risk factors. Vitamin D supplementation may have a modestly beneficial effect on lipid profile and glucose homeostasis, especially in obese individuals or those ≥60 years old and at doses of ≥2000 IU/day (≥50 μg/day). However, it has no effect on the incidence of cardiovascular events. Concerning cancer, vitamin D deficiency is associated with increased incidence of and mortality from several types of cancer, such as colorectal, lung and breast cancer. However, the data on other types of gynecological cancer are inconsistent. Vitamin D supplementation has no effect on cancer incidence, although a modest reduction in cancer-related mortality has been observed. Concerning infections, vitamin D deficiency has been associated with acute respiratory tract infections, including coronavirus disease 2019 (COVID-19). Vitamin D supplementation may decrease the risk of acute respiratory tract infections and the severity of COVID-19 (not the risk of infection). Concerning menopausal symptomatology, vitamin D deficiency may have a negative impact on some aspects, such as sleep disturbances, depression, sexual function and joint pains. However, vitamin D supplementation has no effect on these, except for vulvovaginal atrophy, at relatively high doses, i.e., 40,000-60,000 IU/week (1000-1500 IU/week) orally or 1000 IU/day (25 μg/day) as a vaginal suppository., Competing Interests: Declaration of competing interest, (Copyright © 2022 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
19. Evidence of low vitamin D intakes in the Australian population points to a need for data-driven nutrition policy for improving population vitamin D status.
- Author
-
Dunlop E, Boorman JL, Hambridge TL, McNeill J, James AP, Kiely M, Nowson CA, Rangan A, Cunningham J, Adorno P, Atyeo P, and Black LJ
- Subjects
- Adult, Humans, Diet, Cross-Sectional Studies, Australia epidemiology, Vitamin D, Vitamins, Nutrition Policy, Dietary Supplements, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control
- Abstract
Background: Nearly one in four Australian adults is vitamin D deficient (serum 25-hydroxyvitamin D concentrations [25(OH)D] < 50 nmol L
-1 ) and current vitamin D intakes in the Australian population are unknown. Internationally, vitamin D intakes are commonly below recommendations, although estimates generally rely on food composition data that do not include 25(OH)D. We aimed to estimate usual vitamin D intakes in the Australian population., Methods: Nationally representative food consumption data were collected for Australians aged ≥ 2 years (n = 12,153) as part of the cross-sectional 2011-2013 Australian Health Survey (AHS). New analytical vitamin D food composition data for vitamin D3 , 25(OH)D3 , vitamin D2 and 25(OH)D2 were mapped to foods and beverages that were commonly consumed by AHS participants. Usual vitamin D intakes (µg day-1 ) by sex and age group were estimated using the National Cancer Institute method., Results: Assuming a 25(OH)D bioactivity factor of 1, mean daily intakes of vitamin D ranged between 1.84 and 3.25 µg day-1 . Compared to the estimated average requirement of 10 µg day-1 recommended by the Institute of Medicine, more than 95% of people had inadequate vitamin D intakes. We estimated that no participant exceeded the Institute of Medicine's Upper Level of Intake (63-100 µg day-1 , depending on age group)., Conclusions: Usual vitamin D intakes in Australia are low. This evidence, paired with the high prevalence of vitamin D deficiency in Australia, suggests that data-driven nutrition policy is required to safely increase dietary intakes of vitamin D and improve vitamin D status at the population level., (© 2022 The Authors. Journal of Human Nutrition and Dietetics published by John Wiley & Sons Ltd on behalf of British Dietetic Association.)- Published
- 2023
- Full Text
- View/download PDF
20. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland.
- Author
-
Płudowski P, Kos-Kudła B, Walczak M, Fal A, Zozulińska-Ziółkiewicz D, Sieroszewski P, Peregud-Pogorzelski J, Lauterbach R, Targowski T, Lewiński A, Spaczyński R, Wielgoś M, Pinkas J, Jackowska T, Helwich E, Mazur A, Ruchała M, Zygmunt A, Szalecki M, Bossowski A, Czech-Kowalska J, Wójcik M, Pyrżak B, Żmijewski MA, Abramowicz P, Konstantynowicz J, Marcinowska-Suchowierska E, Bleizgys A, Karras SN, Grant WB, Carlberg C, Pilz S, Holick MF, and Misiorowski W
- Subjects
- Humans, Poland epidemiology, Vitamin D, Vitamins, Cholecalciferol, Calcifediol, Dietary Supplements, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control
- Abstract
Introduction: All epidemiological studies suggest that vitamin D deficiency is prevalent among the Polish general population. Since vitamin D deficiency was shown to be among the risk factors for many diseases and for all-cause mortality, concern about this problem led us to update the previous Polish recommendations. Methods: After reviewing the epidemiological evidence, case-control studies and randomized control trials (RCTs), a Polish multidisciplinary group formulated questions on the recommendations for prophylaxis and treatment of vitamin D deficiency both for the general population and for the risk groups of patients. The scientific evidence of pleiotropic effects of vitamin D as well as the results of panelists' voting were reviewed and discussed. Thirty-four authors representing different areas of expertise prepared position statements. The consensus group, representing eight Polish/international medical societies and eight national specialist consultants, prepared the final Polish recommendations. Results: Based on networking discussions, the ranges of total serum 25-hydroxyvitamin D concentration indicating vitamin D deficiency [<20 ng/mL (<50 nmol/L)], suboptimal status [20-30 ng/mL (50-75 nmol/L)], and optimal concentration [30-50 ng/mL (75-125 nmol/L)] were confirmed. Practical guidelines for cholecalciferol (vitamin D
3 ) as the first choice for prophylaxis and treatment of vitamin D deficiency were developed. Calcifediol dosing as the second choice for preventing and treating vitamin D deficiency was introduced. Conclusions: Improving the vitamin D status of the general population and treatment of risk groups of patients must be again announced as healthcare policy to reduce a risk of spectrum of diseases. This paper offers consensus statements on prophylaxis and treatment strategies for vitamin D deficiency in Poland.- Published
- 2023
- Full Text
- View/download PDF
21. Should vitamin D supplements be prescribed routinely for midlife women?: Released July 13, 2022.
- Author
-
McClung MR
- Subjects
- Female, Humans, Vitamin D, Dietary Supplements, Vitamin D Deficiency epidemiology
- Published
- 2022
- Full Text
- View/download PDF
22. Interdisciplinary Quality Improvement Project Increases Vitamin D Supplementation in Infants.
- Author
-
Diminick NP, Fey JM, Bourque J, Crosby P, Fox L, Tsai-Leonard D, Morin H, Cyr K, Hewitt W, and McElwain LL
- Subjects
- Child, Humans, Infant, Infant, Newborn, Quality Improvement, Vitamin D, Vitamins, Dietary Supplements, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control
- Abstract
Background: American Academy of Pediatrics guidelines recommend 400 IU of vitamin D supplementation daily for certain infants <1 year of age. We aimed to increase the proportion of reported appropriate vitamin D supplementation for infants born at our institution and those who followed up in our resident clinic through 6 months from 49% to 80% over 24 months., Methods: Our interdisciplinary quality improvement effort included vitamin D medication delivery before nursery discharge and family and staff education. The process measure was the percentage of families discharged from birth hospitalization with vitamin D and teaching. The outcome measure was the percentage of families reporting appropriate vitamin D supplementation at 2-, 4-, and 6-month well child visits. The balancing measure was the percentage of infants discharged from the nursery by 2 pm. Data were displayed on Statistical Process Control p charts and established rules for detecting special causes were applied., Results: Baseline and improvement data were collected for 587 hospital discharges and 220 outpatient encounters. The percentage of families discharged with vitamin D increased from 24.8% to 98% from 2016 to 2018. Percent of families reporting appropriate vitamin D supplementation at well child visits increased from 49% to 89% from 2016 to 2018. Overall, the percentage of discharges by 2 pm remained stable at 60%., Conclusion: Bedside medication delivery and education in the newborn nursery improved reported vitamin D supplementation rates in the first 6 months of life. The intervention did not delay newborn hospital discharge., (Copyright © 2022 by the American Academy of Pediatrics.)
- Published
- 2022
- Full Text
- View/download PDF
23. Low socioeconomic status predicts vitamin D status in a cross-section of Irish children.
- Author
-
Scully H, Laird E, Healy M, Crowley V, Walsh JB, and McCarroll K
- Subjects
- Child, Female, Humans, Social Class, Vitamin D, Vitamins, Dietary Supplements, Vitamin D Deficiency epidemiology
- Abstract
Vitamin D is essential for bone and muscle health with adequate status in childhood crucial for normal skeletal development. We aimed to investigate vitamin D status in a convenience sample ( n = 1226) of Irish children (aged 1-17 years) who had serum 25-hydroxyvitamin D (25(OH)D) tested by request of their GP at a Dublin Hospital between 2014 and 2020. We examined predictors including age, sex, season and socioeconomic status (SES). Vitamin D deficiency (<30 nmol/l) was prevalent affecting 23 % and was more common in disadvantaged areas (34 %) and in those aged >12 v . ≤12 years (24 % v . 16 %, P = 0⋅033). The greatest predictor was SES (disadvantaged v . affluent, OR 2⋅18, CI 1⋅34, 3⋅53, P = 0⋅002), followed by female sex (OR 1⋅57, CI 1⋅15, 2⋅14, P = 0⋅005) and winter season (October to February, OR 1⋅40, CI 1⋅07, 1⋅84, P = 0⋅015). A quarter of our sample of children were deficient, rising to one-third in those in disadvantaged areas. Females and those aged over 12 years had a higher prevalence of deficiency. Public health strategies to improve vitamin D status in Irish children, including systematic food fortification may need to be considered to address this issue., (© The Author(s) 2022.)
- Published
- 2022
- Full Text
- View/download PDF
24. Evaluation of a Vitamin D Screening and Treatment Protocol Using a Seasonal Calculator in Athletes.
- Author
-
Hollabaugh WL, Meirick PJ, Matarazzo CP, Burston AM, Camery ME, Ferrill-Moseley KA, Bley JA, Pennings JS, Fitch RW, Tanner SB, and Karpinos AR
- Subjects
- Athletes, Clinical Protocols, Humans, Seasons, Vitamin D, Dietary Supplements, Vitamin D Deficiency diagnosis, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology
- Abstract
Abstract: Vitamin D is important in musculoskeletal health, and low serum vitamin D concentration is common in athletes. This study implemented a vitamin D screening and supplementation protocol in a cohort of National Collegiate Athletic Association Division I athletes using summer 25-hydroxyvitamin D concentration and a seasonal variation calculator to achieve sufficient vitamin D concentration year-round. After implementation of the Vitamin D Protocol, there was a nonsignificant difference in athletes with sufficient winter vitamin D concentrations (72.6%) compared with summer vitamin D concentrations (66.1%) (P = 0.40). The Seasonal Variation Calculator predicted winter vitamin D concentrations (8 ± 18 ng·mL-1) higher than actual winter vitamin D concentrations (P < 0.01). While most athletes (78%) believed vitamin D was important for athletic performance, athlete compliance to the Vitamin D Protocol was inconsistent. In the future, adjustment of vitamin D screening and supplementation protocols may help athletes achieve sufficient vitamin D status year-round., (Copyright © 2022 by the American College of Sports Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
25. Vitamin D Status in Pediatric and Young Adult Cystic Fibrosis Patients. Are the New Recommendations Effective?
- Author
-
Mangas-Sánchez C, Garriga-García M, Serrano-Nieto MJ, García-Romero R, Álvarez-Beltrán M, Crehuá-Gaudiza E, Muñoz-Codoceo R, Suárez-Cortina L, Vicente-Santamaría S, Martínez-Costa C, Díaz-Martin JJ, Bousoño-García C, and González-Jiménez D
- Subjects
- Adult, Cohort Studies, Female, Humans, Male, Risk, Safety, Vitamin D blood, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control, Young Adult, Cystic Fibrosis blood, Dietary Supplements, Nutritional Status, Recommended Dietary Allowances, Vitamin D administration & dosage
- Abstract
Introduction: In recent years, guidelines for vitamin D supplementation have been updated and prophylactic recommended doses have been increased in patients with cystic fibrosis (CF)., Objective: To evaluate safety and efficacy of these new recommendations., Results: Two cohorts of pancreatic insufficient CF patients were compared before (cohort 1: 179 patients) and after (cohort 2: 71 patients) American CF Foundation and European CF Society recommendations were published. Cohort 2 patients received higher Vitamin D doses: 1509 (1306-1711 95% CI) vs 1084 (983-1184 95% CI) IU/Day ( p < 0.001), had higher 25 OH vitamin D levels: 30.6 (27.9-33.26 95% CI) vs. 27.4 (25.9-28.8 95% CI) ng/mL ( p = 0.028), and had a lower prevalence of insufficient vitamin D levels (<30 ng/mL): 48% vs 65% ( p = 0.011). Adjusted by confounding factors, patients in cohort 1 had a higher risk of vitamin D insufficiency: OR 2.23 (1.09-4.57 95% CI) ( p = 0.028)., Conclusion: After the implementation of new guidelines, CF patients received higher doses of vitamin D and a risk of vitamin D insufficiency decreased. Despite this, almost a third of CF patients still do not reach sufficient serum calcidiol levels.
- Published
- 2021
- Full Text
- View/download PDF
26. Vitamin D status and supplementation in Antarctica: a systematic review and meta- analysis.
- Author
-
Cabalín C, Iturriaga C, Pérez-Mateluna G, Echeverría D, Camargo CA Jr, and Borzutzky A
- Subjects
- Antarctic Regions, Humans, Seasons, Vitamin D, Dietary Supplements, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology
- Abstract
Living at high latitudes is associated with vitamin D (VD) deficiency. An ideal setting to study this is the Antarctic continent, which has temporary inhabitants, but the magnitude of the effect of living in Antarctica and the effects of VD supplementation on this population remain unclear. We performed a systematic review and meta-analysis to assess the effect of temporary residence in Antarctica and impact of VD supplementation on VD status of this population. Random-effects meta-analyses were performed to assess serum 25-hydroxyvitamin D (25(OH)D) concentration changes after Antarctic residence (13 studies, 294 subjects) and after VD supplementation (5 studies, 213 subjects). Serum 25(OH)D mean difference after temporary residence in Antarctica was -15.0 nmol/L (95%CI: -25.9, -4.2; I²=92%). Subgroup meta-analyses of studies evaluating Antarctic summer and winter stays showed 25(OH)D only decreases when overwintering (winter 25(OH)D change -17.0 nmol/L [95%CI: -24.1, -9.8; I²=83%] vs. summer 25(OH)D change 1.3 nmol/L [95%CI: -14.6, 17.1; I²=86%]). The meta-analysis of VD supplementation studies in Antarctica showed a mean 25(OH)D increase after supplementation of 10.8 nmol/L (95%CI: 3.3, 18.3; I²=88%). In conclusion, VD status significantly worsens after inhabiting Antarctica, particularly when over-wintering. VD supplementation can prevent worsening of VD status and should be considered in this population.
- Published
- 2021
- Full Text
- View/download PDF
27. The determinants and longitudinal changes in vitamin D status in middle-age: a Northern Finland Birth Cohort 1966 study.
- Author
-
Ikonen H, Lumme J, Seppälä J, Pesonen P, Piltonen T, Järvelin MR, Herzig KH, Miettunen J, Niinimäki M, Palaniswamy S, Sebert S, and Ojaniemi M
- Subjects
- Adult, Animals, Female, Finland epidemiology, Humans, Male, Middle Aged, Seasons, Vitamin D, Vitamins, Dietary Supplements, Vitamin D Deficiency epidemiology
- Abstract
Purpose: Populations living in the Nordic countries are at high risk for vitamin D (VitD) deficiency or insufficiency. To reduce the risk, nationwide interventions based on food fortification and supplementation are being implemented. However, there is limited evidence about the impact of such public health campaigns on target populations., Methods: We studied an unselected sample of 3650 participants (56.2% females) from the longitudinal Northern Finland Birth Cohort 1966 with repeated measures of serum 25-hydroxyvitamin D [25(OH)D] at ages 31 (1997) and 46 (2012-2013). Timepoints corresponded to the period before and during the food fortification. We examined the effect of VitD intake from the diet and supplementation, body mass index and previous 25(OH)D concentration on 25(OH)D concentration at 46 years using a multivariable linear regression analysis. A 25(OH)D z score adjusted for sex, season, latitude and technical effect was used in the analysis., Results: We observed an increase of 10.6 nmol/L in 25(OH)D, when the baseline 25(OH)D was 54.3 nmol/L. The prevalence of serum 25(OH)D below < 50 nmol/L was halved. The changes were found for both sexes and were more pronounced in winter compared to summer months. Regular VitD supplementation had a significant positive effect on 25(OH)D at the age of 46, as well as had the dietary intake of fortified dairy products and fish, and the previous 25(OH)D concentration. However, the intake of fat-spreads albeit VitD-fortified, did not predict 25(OH)D., Conclusion: Our results demonstrated the positive impact of the fortification programme on VitD status in middle-aged population., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
28. [To D or not to D ? Why and how to treat vitamin D deficiency in older patients].
- Author
-
Cantista M, Quiaios L, Nguyen S, Büla C, and D'Amelio P
- Subjects
- Administration, Oral, Aged, Humans, Vitamin D therapeutic use, Vitamins therapeutic use, Dietary Supplements, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology
- Abstract
Vitamin D deficiency is so frequent in older patients (aged 65 years and older) that the international consensus does not recommend routine vitamin D measurement. Assessment of overall health status is a cornerstone before considering vitamin D supplementation, as the effect of vitamin D supplementation has only been demonstrated in vulnerable or dependent but not for robust older patients. The effect of the different modalities of oral vitamin D supplementation are equivalent : 800-1'200 IU/day, 10'000 IU/week or 30'000-50'000 IU/month. Monitoring of vitamin D blood level monitoring is not necessary because of a large therapeutic margin. In the presence of osteoporosis, a dietary or supplementation intake of 1'200 mg per day of calcium should be added., Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
- Published
- 2021
29. Potential benefit of vitamin D supplementation in people with respiratory illnesses, during the COVID-19 pandemic.
- Author
-
Chetty VV and Chetty M
- Subjects
- COVID-19 diagnosis, COVID-19 epidemiology, COVID-19 prevention & control, Comorbidity, Cytokine Release Syndrome immunology, Cytokine Release Syndrome prevention & control, Cytokine Release Syndrome virology, Disease Susceptibility blood, Disease Susceptibility immunology, Humans, Pandemics, Respiratory Distress Syndrome immunology, Respiratory Distress Syndrome prevention & control, Risk Factors, Severity of Illness Index, Tuberculosis blood, Tuberculosis epidemiology, Vitamin D blood, Vitamin D Deficiency complications, Vitamin D Deficiency epidemiology, Vitamin D Deficiency immunology, COVID-19 immunology, Dietary Supplements, Tuberculosis immunology, Vitamin D administration & dosage, Vitamin D Deficiency diet therapy
- Abstract
This review describes the evidence for the potential benefit of vitamin D supplementation in people with respiratory diseases who may have a higher susceptibility to coronavirus disease 2019 (COVID-19) infection and its consequences. Clinical evidence indicates that vitamin D may reduce the risk of both upper and lower respiratory tract infections and offers benefit particularly in people with vitamin D deficiency. Some evidence exists for a higher incidence of active tuberculosis (TB) in patients who are deficient in vitamin D. An association between low levels of 25(OH)D (the active form of vitamin D) and COVID-19 severity of illness and mortality has also been reported. In addition, low 25(OH)D levels are associated with poor outcomes in acute respiratory distress syndrome (ARDS). The cytokine storm experienced in severe COVID-19 infections results from excessive release of pro-inflammatory cytokines. Due to its immunomodulatory effects, adequate vitamin D levels may cause a decrease in the pro-inflammatory cytokines and an increase in the anti-inflammatory cytokines during COVID-19 infections. Vitamin D deficiency was found in 82.2% of hospitalized COVID-19 cases and 47.2% of population-based controls (p < 0.0001). The available evidence warrants an evaluation of vitamin D supplementation in susceptible populations with respiratory diseases, such as TB, and particularly in those who are deficient in vitamin D. This may mitigate against serious complications of COVID-19 infections or reduce the impact of ARDS in those who have been infected., (© 2021 The Authors. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.)
- Published
- 2021
- Full Text
- View/download PDF
30. Effect of vitamin D supplementation on markers of cardiometabolic risk in children and adolescents: A meta-analysis of randomized clinical trials.
- Author
-
Cai B, Luo X, Zhang P, Luan Y, Cai X, and He X
- Subjects
- Adolescent, Age Factors, Biomarkers blood, Blood Glucose metabolism, Cardiometabolic Risk Factors, Child, Child, Preschool, Cholesterol blood, Female, Humans, Male, Metabolic Syndrome diagnosis, Metabolic Syndrome epidemiology, Randomized Controlled Trials as Topic, Risk Assessment, Time Factors, Treatment Outcome, Vitamin D adverse effects, Vitamin D Deficiency diagnosis, Vitamin D Deficiency epidemiology, Blood Glucose drug effects, Dietary Supplements adverse effects, Metabolic Syndrome prevention & control, Triglycerides blood, Vitamin D therapeutic use, Vitamin D Deficiency drug therapy
- Abstract
Background and Aims: An increasing attention to the effect of vitamin D supplementation on cardiometabolic risk markers in children and adolescents has been gained recently. However, the results are inconsistent. Therefore, we conducted a meta-analysis to examine the effect of vitamin D supplementation on cardiometabolic risk markers in children and adolescents., Methods and Results: Eligible randomized controlled trials (RCTs) were identified by searching PubMed, EMBASE and Web of Science. The results of this study are synthetized and reported in accordance with the PRISMA statement. GRADE system was used to assess the certainty of evidence. A total of 9 RCTs were identified and included in the meta-analysis. We found that vitamin D supplementation did not affect the changes of cardiometabolic risk markers including high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglycerides (TG), body mass index (BMI), waist circumferences, systolic blood pressure (SDP) and diastolic blood pressure (DBP). However, vitamin D supplementation showed a beneficial effect on fasting glucose (MD, -1.54 mg/dl, 95% CI -2.98 to -0.10) and TG (MD, -24.76 mg/dl, 95% CI -37.66 to -11.86) in the sub-group analysis of total vitamin D supplementation ≥ 200,000 IU., Conclusions: Vitamin D supplementation appeared to have a beneficial effect on reducing fasting glucose and TG level when total vitamin D supplementation ≥200,000 IU but not HDL-C, LDL-C TC, blood pressure and waist circumferences levels in children and adolescents. Further studies are needed to address this issue., Competing Interests: Declaration of competing interest The authors declare no conflict of interest., (Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
31. Vitamin D Knowledge, Attitudes and Practices of Polish Medical Doctors.
- Author
-
Zgliczyński WS, Rostkowska OM, and Sarecka-Hujar B
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Poland, Dietary Supplements, Health Knowledge, Attitudes, Practice, Physicians, Vitamin D administration & dosage, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency diet therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control, Vitamins administration & dosage
- Abstract
Background Vitamin D deficiency occurs in as much as 90-95% of the Polish population, although this condition is known to cause negative long-term health implications. The role of medical doctors in advising proper supplementation, monitoring and correcting the levels of 25-hydroxyvitamin D in individuals is of great importance and should be used to help mitigate its common deficits. The aim of this study was to evaluate knowledge, attitudes and practices of Polish physicians regarding vitamin D supplementation in order to identify areas for improvement and determinants for the knowledge gaps. Methods The study group comprised 701 medical doctors aged 32.1 ± 5.3 years on average, mostly women (71.61%). An original survey questionnaire was developed for the purpose of the study. Results The mean vitamin D knowledge score was 6.8 ± 2.3 (in a scale 0-13) and was related to gender ( p < 0.001), type of specialization ( p = 0.032), D3 supplements use ( p < 0.001), recommending supplementation to patients ( p = 0.005), to relatives and friends ( p < 0.001) and to healthy adults ( p < 0.001). In terms of self-administration, 14% of respondents take vitamin D all-year-round while 24% only in autumn and winter. 25% of respondents monitor their vitamin D (25-hydroxyvitamin D) serum concentration. Most participants (61%) did not recommend supplementing vitamin D to their patients on a regular basis. Conclusions The study indicates that medical doctors in Poland need to have more training and education on vitamin D supplementation in order to better address the problem of its deficits in the population.
- Published
- 2021
- Full Text
- View/download PDF
32. Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies.
- Author
-
Petrelli F, Luciani A, Perego G, Dognini G, Colombelli PL, and Ghidini A
- Subjects
- COVID-19 blood, COVID-19 mortality, COVID-19 prevention & control, Humans, Immunity, Innate drug effects, Incidence, Observational Studies as Topic, Odds Ratio, Prognosis, Risk, Severity of Illness Index, Survival Analysis, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency mortality, Vitamin D Deficiency prevention & control, COVID-19 epidemiology, Dietary Supplements, Pandemics, SARS-CoV-2 pathogenicity, Vitamin D therapeutic use, Vitamin D Deficiency epidemiology
- Abstract
Vitamin D modulates the systemic inflammatory response through interaction with immune system. As such, it has a possible protective role against the risk of respiratory tract infections and other diseases. It may be useful in particular, during COVID-19 pandemic. PubMed, the Cochrane Library, and EMBASE were searched from inception until January 31, 2021, for observational or clinical studies reporting the prognosis (and therapeutic effect) of COVID-19 infection in patients with deficient vitamin D levels. The infection rate, severity, and death from COVID-19 infection were pooled to provide an odds ratio with a 95 % confidence interval (OR 95 % CI). An OR > 1 was associated with the worst outcome in deficient compared with nondeficient patients. We assessed the association between vitamin D and risk, severity, and mortality for COVID-19 infection, through a review of 43 observational studies. Among subjects with deficient vitamin D values, risk of COVID-19 infection was higher compared to those with replete values (OR = 1.26; 95 % CI, 1.19-1.34; P < .01). Vitamin D deficiency was also associated with worse severity and higher mortality than in nondeficient patients (OR = 2.6; 95 % CI, 1.84-3.67; P < .01 and OR = 1.22; 95 % CI, 1.04-1.43; P < .01, respectively). Reduced vitamin D values resulted in a higher infection risk, mortality and severity COVID-19 infection. Supplementation may be considered as preventive and therapeutic measure., (Copyright © 2021 Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
33. Effects of select dietary supplements on the prevention and treatment of viral respiratory tract infections: a systematic review of randomized controlled trials.
- Author
-
Shokri-Mashhadi N, Kazemi M, Saadat S, and Moradi S
- Subjects
- COVID-19 complications, COVID-19 epidemiology, Drugs, Chinese Herbal therapeutic use, Humans, Lactobacillus physiology, Panax chemistry, Quercetin therapeutic use, Randomized Controlled Trials as Topic statistics & numerical data, SARS-CoV-2 physiology, Vitamin D therapeutic use, Vitamin D Deficiency complications, Vitamin D Deficiency diet therapy, Vitamin D Deficiency epidemiology, beta-Glucans therapeutic use, COVID-19 prevention & control, COVID-19 therapy, Dietary Supplements classification, Respiratory Tract Infections epidemiology, Respiratory Tract Infections prevention & control, Respiratory Tract Infections therapy, Virus Diseases epidemiology, Virus Diseases prevention & control, Virus Diseases therapy
- Abstract
Introduction : Viral respiratory tract infections (RTIs) have been recognized as a global public health burden. Despite current theories about their effectiveness, the true benefits of dietary supplements on the prevention and treatment of viral RTIs remain elusive, due to contradictory reports. Hence, we aimed to evaluate the effectiveness of dietary supplements on the prevention and treatment of viral RTIs. Areas covered : We systematically searched databases of PubMed, Web of Science, Scopus, and Google Scholar through 4 March 2020, to identify randomized controlled trials that evaluated the effects of consuming selected dietary supplements on the prevention or treatment of viral RTIs. Expert opinion : Thirty-nine randomized controlled trials (n = 16,797 participants) were eligible and included. Namely, vitamin D supplementation appeared to improve viral RTIs across cohorts particulate in those with vitamin D deficiency. Among the evaluated dietary supplements, specific lactobacillus strains were used most commonly with selected prebiotics that showed potentially positive effects on the prevention and treatment of viral RTIs. Further, ginseng extract supplementation may effectively prevent viral RTIs as adjuvant therapy. However, longitudinal research is required to confirm these observations and address the optimal dose, duration, and safety of dietary supplements being publicly recommended.
- Published
- 2021
- Full Text
- View/download PDF
34. Supplementation of the population during the COVID-19 pandemic with vitamins and micronutrients - how much evidence is needed?
- Author
-
Schuetz P, Gregoriano C, and Keller U
- Subjects
- Ascorbic Acid Deficiency epidemiology, Ascorbic Acid Deficiency immunology, Ascorbic Acid Deficiency prevention & control, Ascorbic Acid Deficiency therapy, COVID-19 immunology, COVID-19 prevention & control, COVID-19 therapy, Deficiency Diseases epidemiology, Deficiency Diseases immunology, Deficiency Diseases therapy, Humans, Magnesium Deficiency epidemiology, Magnesium Deficiency immunology, Magnesium Deficiency prevention & control, Magnesium Deficiency therapy, Micronutrients therapeutic use, Risk Factors, SARS-CoV-2, Switzerland, Treatment Outcome, Vitamin B 12 Deficiency epidemiology, Vitamin B 12 Deficiency immunology, Vitamin B 12 Deficiency prevention & control, Vitamin B 12 Deficiency therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency immunology, Vitamin D Deficiency prevention & control, Vitamin D Deficiency therapy, Zinc deficiency, COVID-19 epidemiology, Deficiency Diseases prevention & control, Dietary Supplements, Evidence-Based Medicine, Trace Elements therapeutic use, Vitamins therapeutic use
- Published
- 2021
- Full Text
- View/download PDF
35. Early-onset climacterium is not associated with impaired vitamin D status: a population-based study.
- Author
-
Lumme JE, Savukoski SM, Suvanto ETJ, Pesonen PRO, Auvinen JP, Sebert S, Hyppönen E, Järvelin MR, Puukka KS, Herzig KH, Oura P, Ojaniemi M, and Niinimäki M
- Subjects
- Cross-Sectional Studies, Female, Humans, Middle Aged, Vitamin D, Vitamins, Dietary Supplements, Vitamin D Deficiency complications, Vitamin D Deficiency epidemiology
- Abstract
Objective: To investigate vitamin D status in women with the onset of the climacteric phase by age 46 as both early menopause and inadequate vitamin D status may increase the risk of adverse health outcomes., Methods: A cross-sectional study included 2,544, 46-year-old women from a birth cohort. Women were divided into the following two groups according to their menstrual history and follicle-stimulating hormone (FSH) concentration: 1) climacteric (FSH ≥25 IU/L and amenorrhea ≥4 mo, n = 351) and 2) preclimacteric women (FSH <25 IU/L and having regular/irregular menstrual cycles, n = 2,193). Serum 25-hydroxyvitamin D (25(OH)D) concentrations were compared between the groups. A linear regression model was performed to investigate which factors are associated with 25(OH)D status., Results: Mean serum 25(OH)D concentrations were higher in climacteric compared with preclimacteric women (68.1 ± 19.8 nmol/L vs 65.2 ± 19.3 nmol/L, P = 0.01). However, in the linear regression model, climacteric status was not associated with 25(OH)D status (multivariable adjusted mean difference 4.5 nmol/L, 95% confidence interval -1.4 to 10.4, P = 0.137). A total of 76 of the climacteric women were using systemic estrogen hormone therapy (HT). In a subanalysis, including only climacteric women, the use of HT was associated with higher 25(OH)D status (multivariable adjusted mean difference 5.9 nmol/L, 95% confidence interval 1.3-10.5, P = 0.013)., Conclusions: The onset of the climacteric phase by age 46 was not associated with inadequate 25(OH)D concentrations, whereas HT use was associated with higher 25(OH)D status in women with early-onset climacterium., Competing Interests: Financial disclosures/conflicts of interest: E.H. has received grants from National Health and Medical Research Council, Australian Research Council, Tour de Cure, and Medical Research Future Fund. The rest of the authors have nothing to disclose., (Copyright © 2021 by The North American Menopause Society.)
- Published
- 2021
- Full Text
- View/download PDF
36. Association of vitamin D pathway gene polymorphisms with vitamin D level during pregnancy was modified by season and vitamin D supplement.
- Author
-
Wu J, Shao B, Xin X, Luo W, Mo M, Jiang W, Si S, Wang S, Shen Y, and Yu Y
- Subjects
- Adult, China, Cohort Studies, Female, Humans, Polymorphism, Single Nucleotide genetics, Pregnancy Complications epidemiology, Pregnancy Complications genetics, Seasons, Vitamin D Deficiency epidemiology, Vitamin D Deficiency genetics, Dietary Supplements, Pregnancy blood, Pregnancy genetics, Pregnancy statistics & numerical data, Vitamin D blood, Vitamin D genetics, Vitamin D metabolism, Vitamin D-Binding Protein genetics
- Abstract
Background & Aims: This study aims to explore the associations of vitamin D (VD) metabolic pathway gene with 25(OH)D level in pregnant women and the interactions of SNP with season and VD supplement., Methods: A total of 2658 pregnant women were selected from Zhoushan Pregnant Women Cohort study. Gestational 25(OH)D level and single nucleotide polymorphism (SNP) of VD metabolic pathway gene were detected. Multilinear regression models were used to estimate associations of SNPs with gestational 25(OH)D levels. Stratified analyses were performed to test the interactions of SNP with season and VD supplements., Results: The mutations of rs2298849 and rs7041 on the GC gene were respectively associated with higher 25(OH)D in the first and third trimester; the mutations of seven SNPs (rs1155563, rs16846876, rs17467825, rs2282679, rs2298850, rs3755967, and rs4588) on the GC gene were respectively associated with lower 25(OH)D both in the first and third trimester, and lower changes in 25(OH)D during late pregnancy. The mutations of above seven SNPs, except for rs1155563, were also respectively associated with lower 25(OH)D in the second trimester, but to a lesser extent; Besides, pregnant women with mutation on CYP24A1-rs2209314 had a higher increment in 25(OH)D than their counterparts in the second trimester. The increasing dose effect of Gc isoform on 25(OH)D was observed. The associations of GC and LRP2 genes with 25(OH)D modified by season and VD supplements., Conclusions: The polymorphisms of VD metabolic pathway gene were associated with gestational 25(OH)D, and the associations differ by seasons and VD supplements. Gc isoform exerted a profound influence on gestational 25(OH)D., Competing Interests: Conflict of interest The authors declare that they have no conflict of interest., (Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
37. Vitamin D Deficiency in Older Patients-Problems of Sarcopenia, Drug Interactions, Management in Deficiency.
- Author
-
Kupisz-Urbańska M, Płudowski P, and Marcinowska-Suchowierska E
- Subjects
- Aged, Aged, 80 and over, Comorbidity, Drug Interactions, Frail Elderly, Humans, Osteoporosis blood, Osteoporosis etiology, Osteoporosis prevention & control, Polypharmacy, Quality of Life, Sarcopenia blood, Sarcopenia etiology, Sarcopenia prevention & control, Vitamin D administration & dosage, Vitamin D blood, Vitamin D metabolism, Vitamin D Deficiency blood, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Dietary Supplements, Osteoporosis epidemiology, Sarcopenia epidemiology, Vitamin D analogs & derivatives, Vitamin D Deficiency complications
- Abstract
Vitamin D deficiency frequently occurs in older people, especially in individuals with comorbidity and polypharmacotherapy. In this group, low vitamin D plasma concentration is related to osteoporosis, osteomalacia, sarcopenia and myalgia. Vitamin D levels in humans is an effect of the joint interaction of all vitamin D metabolic pathways. Therefore, all factors interfering with individual metabolic stages may affect 25-hydroxyvitamin D plasma concentration. The known factors affecting vitamin D metabolism interfere with cytochrome CYP3A4 activity. There is another group of factors that impairs intestinal vitamin D absorption. The phenomenon of drugs and vitamin D interactions is observed first and foremost in patients with comorbidity. This is a typical situation, where the absence of "hard evidence" is not synonymous with the possible lack of adverse effects. Osteoporosis and sarcopenia (generalized and progressive decrease of skeletal muscle mass and strength) are some of the musculoskeletal consequences of hypovitaminosis D. These consequences are related to an increased risk of adverse outcomes, including bone fractures, physical disabilities, and a lower quality of life. This can lead not only to an increased risk of falls and fractures but is also one of the main causes of frailty syndrome in the aging population. Generally, Vitamin D plasma concentration is significantly lower in subjects with osteoporosis and muscle deterioration. In some observational and uncontrolled treatment studies, vitamin D supplementation resulted in a reduction of proximal myopathy and muscle pain. The most conclusive results were found in subjects with severe vitamin D deficiency and in patients avoiding large doses of vitamin D. However, the role of vitamin D in muscle pathologies is not clear and research has provided conflicting results. This is plausibly due to the heterogeneity of the subjects, vitamin D doses and environmental factors. This report presents data on some problems with vitamin D deficiency in the elderly population and the management of vitamin D deficiency D in successful or unsuccessful aging.
- Published
- 2021
- Full Text
- View/download PDF
38. Perspective: Vitamin D supplementation prevents rickets and acute respiratory infections when given as daily maintenance but not as intermittent bolus: implications for COVID-19.
- Author
-
Griffin G, Hewison M, Hopkin J, Kenny RA, Quinton R, Rhodes J, Subramanian S, and Thickett D
- Subjects
- Humans, Pandemics, SARS-CoV-2, COVID-19, Dietary Supplements, Respiratory Tract Infections prevention & control, Rickets prevention & control, Vitamin D therapeutic use, Vitamin D Deficiency drug therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control
- Abstract
The value of vitamin D supplementation in the treatment or prevention of various conditions is often viewed with scepticism as a result of contradictory results of randomised trials. It is now becoming apparent that there is a pattern to these inconsistencies. A recent large trial has shown that high-dose intermittent bolus vitamin D therapy is ineffective at preventing rickets - the condition that is most unequivocally caused by vitamin D deficiency. There is a plausible biological explanation since high-dose bolus replacement induces long-term expression of the catabolic enzyme 24-hydroxylase and fibroblast growth factor 23, both of which have vitamin D inactivating effects. Meta-analyses of vitamin D supplementation in prevention of acute respiratory infection and trials in tuberculosis and other conditions also support efficacy of low dose daily maintenance rather than intermittent bolus dosing. This is particularly relevant during the current COVID-19 pandemic given the well-documented associations between COVID-19 risk and vitamin D deficiency. We would urge that clinicians take note of these findings and give strong support to widespread use of daily vitamin D supplementation., (© Royal College of Physicians 2021. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
39. Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?
- Author
-
Ames BN, Grant WB, and Willett WC
- Subjects
- Black or African American, Alzheimer Disease etiology, Alzheimer Disease prevention & control, Antigens, Neoplasm, Dementia etiology, Dementia prevention & control, Diabetes Mellitus etiology, Diabetes Mellitus prevention & control, Female, Humans, Male, Prevalence, Status Asthmaticus etiology, Status Asthmaticus prevention & control, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency complications, COVID-19 etiology, COVID-19 prevention & control, Cholecalciferol administration & dosage, Dietary Supplements, Health Status Disparities, Vitamin D Deficiency epidemiology, Vitamin D Deficiency ethnology
- Abstract
African Americans have higher incidence of, and mortality from, many health-related problems than European Americans. They also have a 15 to 20-fold higher prevalence of severe vitamin D deficiency. Here we summarize evidence that: (i) this health disparity is partly due to insufficient vitamin D production, caused by melanin in the skin blocking the UVB solar radiation necessary for its synthesis; (ii) the vitamin D insufficiency is exacerbated at high latitudes because of the combination of dark skin color with lower UVB radiation levels; and (iii) the health of individuals with dark skin can be markedly improved by correcting deficiency and achieving an optimal vitamin D status, as could be obtained by supplementation and/or fortification. Moderate-to-strong evidence exists that high 25-hydroxyvitamin D levels and/or vitamin D supplementation reduces risk for many adverse health outcomes including all-cause mortality rate, adverse pregnancy and birth outcomes, cancer, diabetes mellitus, Alzheimer's disease and dementia, multiple sclerosis, acute respiratory tract infections, COVID-19, asthma exacerbations, rickets, and osteomalacia. We suggest that people with low vitamin D status, which would include most people with dark skin living at high latitudes, along with their health care provider, consider taking vitamin D
3 supplements to raise serum 25-hydroxyvitamin D levels to 30 ng/mL (75 nmol/L) or possibly higher.- Published
- 2021
- Full Text
- View/download PDF
40. Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health: JACC Focus Seminar.
- Author
-
Michos ED, Cainzos-Achirica M, Heravi AS, and Appel LJ
- Subjects
- Calcium metabolism, Humans, Vitamin D metabolism, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control, Calcium administration & dosage, Cardiovascular Diseases prevention & control, Dietary Supplements, Vitamin D administration & dosage
- Abstract
Vitamin D and calcium supplements are commonly used, often together, to optimize bone health. Multiple observational studies have linked low serum 25-hydroxyvitamin D concentrations with increased cardiovascular risk. However, subsequent randomized controlled trials (RCTs) failed to demonstrate cardiovascular benefit with vitamin D supplementation. Although vitamin D supplements do not appear to be harmful for cardiovascular health, the lack of benefit in RCTs should discourage their use for this purpose, favoring optimizing vitamin D status through healthy lifestyles such as specific foods and modest sunlight exposure. Furthermore, some (but not all) observational and RCT studies of calcium supplementation have suggested potential for cardiovascular harm. Therefore, calcium supplementation should be used cautiously, striving for recommended intake of calcium predominantly from food sources. In this review, the authors examine the currently available evidence investigating whether vitamin D and calcium supplements are helpful, harmful, or neutral for cardiovascular health., Competing Interests: Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2021 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
41. Do Low Vitamin D Levels Increase COVID-19 Risk?
- Subjects
- COVID-19, Coronavirus Infections epidemiology, Humans, Patient Acuity, Pneumonia, Viral epidemiology, SARS-CoV-2, Severity of Illness Index, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency epidemiology, Betacoronavirus, Coronavirus Infections prevention & control, Dietary Supplements statistics & numerical data, Pandemics prevention & control, Pneumonia, Viral prevention & control, Vitamin D therapeutic use, Vitamin D Deficiency prevention & control
- Abstract
Two recent studies arrive at different conclusions.
- Published
- 2020
- Full Text
- View/download PDF
42. A systematic review on the efficacy of vitamin D supplementation on diabetic peripheral neuropathy.
- Author
-
Yammine K, Wehbe R, and Assi C
- Subjects
- Adult, Aged, Biomarkers blood, Diabetic Neuropathies diagnosis, Diabetic Neuropathies epidemiology, Female, Glycated Hemoglobin metabolism, Humans, Male, Middle Aged, Pain Measurement, Time Factors, Treatment Outcome, Vitamin D adverse effects, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency diagnosis, Vitamin D Deficiency epidemiology, Diabetic Neuropathies drug therapy, Dietary Supplements adverse effects, Vitamin D therapeutic use, Vitamin D Deficiency drug therapy
- Abstract
Background & Aims: Vitamin D deficiency is known to be prevalent in patients with diabetes and in particular in those having symptoms of diabetic peripheral neuropathy (DN). Thus, it is worthy to investigate whether a supplementation of vitamin D would improve pain among those having diabetes and DN., Methods: A systematic literature search was performed to identify studies that reported the impact of vitamin D supplementation on the signs and symptoms of DN. Random effect models were used to meta-analyze effect sizes. Quality assessment was also performed., Results: Four studies including 364 patients met the inclusion criteria. Meta-analytical results were as follows: Serum Vitamin D level change of 1.39 (95% CI = 1.220 to 1.573, p = 0.008), HbA1c change of 0.134 (95% CI = -0.153 to 0.418, p = 0.3), McGill Pain Questionnaire score of 1.14 (95% CI = 1.222 to 1.672, p < 0.0001), all in favor of the vitamin D supplementation group. Non-meta-analytical results of all individual studies showed significant amelioration of pain scores. One study reported no significant change in nerve conduction study. Pain improvement was not correlated to baseline or change in serum vitamin D level., Conclusion: Vitamin D supplementation could be an added value in the treatment of painful peripheral diabetic neuropathy. Amelioration in pain might be related to the absolute value of vitamin D attained following supplementation. The findings of this review are promising and further research with large sample randomized trials is warranted., Competing Interests: Conflict of Interest None., (Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
43. Reassessing vitamin D supplementation in preterm infants: a prospective study and review of the literature.
- Author
-
Zung A, Topf-Olivestone C, Shinwell ES, Hofi L, Juster-Reicher A, and Flidel-Rimon O
- Subjects
- Adult, Female, Follow-Up Studies, Humans, Infant, Newborn, Israel epidemiology, Male, Prognosis, Prospective Studies, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Vitamins blood, Young Adult, Biomarkers blood, Dietary Supplements, Infant, Premature blood, Vitamin D administration & dosage, Vitamin D Deficiency drug therapy, Vitamins administration & dosage
- Abstract
Objectives Recommendations for vitamin D (VitD) intake and target serum levels of 25(OH)D in preterm infants are diverse. We hypothesized that preterm infants with low birth weight (BW) have low dietary intake of VitD and therefore should be supplemented with higher amounts of VitD. Methods Infants with BW < 2 kg were supplemented with 600 units of VitD a day during the first 2-6 weeks of life, whereas infants with BW>2 kg continued with the routine supplementation of 400 units of VitD daily. Serum levels of 25(OH)D, calcium, phosphorous, alkaline phosphatase (AP) and parathyroid hormone (PTH) were assessed 24 h after birth and before discharge. The total daily intake of vitD was calculated in each infant. Results Sixty-two infants were enrolled, 49 with BW < 2 kg. After birth, only 24% had sufficient levels of 25(OH)D, whereas before discharge 45 of 54 infants (83%) available for analysis reached sufficient levels of 25(OH)D. All 54 infants demonstrated significant elevation in serum levels of calcium, phosphorous, AP and significant reduction in PTH levels. The total daily intake of VitD was lower than recommended (800-1000 IU/d) in 16 of 45 infants with BW < 2 kg (36%) and in all nine infants with BW>2 kg. Nevertheless, only 2 of 25 infants with insufficient intake of VitD demonstrated insufficient levels of serum 25(OH)D. No case of vitamin D excess was recorded. Conclusions Increased supplementation of VitD (600 IU/d) for premature newborns with BW < 2 kg is effective in increasing both total daily intake of VitD and serum levels of 25(OH)D.
- Published
- 2020
- Full Text
- View/download PDF
44. Vitamin D Deficiency in Mexican Pregnant Women: Is Supplementation with ≤400 IU/day Enough?
- Author
-
Perichart-Perera O, González-Leyva CP, González-Ludlow I, Tolentino-Dolores M, Solis-Paredes M, Reyes-Muñoz E, Borboa-Olivares H, Sánchez-Martínez M, Parra-Hernández S, Monterrubio-Flores E, Schnaas Y Arrieta L, Guzmán-Huerta M, and Estrada-Gutierrez G
- Subjects
- Cohort Studies, Female, Humans, Mexico epidemiology, Pregnancy, Pregnancy Complications epidemiology, Prevalence, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency epidemiology, Cholecalciferol administration & dosage, Dietary Supplements, Maternal Nutritional Physiological Phenomena physiology, Nutritional Requirements, Obesity, Maternal metabolism, Pregnancy Complications diet therapy, Pregnancy Complications prevention & control, Pregnant Women, Vitamin D Deficiency diet therapy, Vitamin D Deficiency prevention & control
- Abstract
Controversy remains surrounding vitamin D routine supplementation in healthy pregnancy, and the doses are unclear. The aim of this study was to describe maternal vitamin D status throughout pregnancy in a group of Mexican women and evaluate the effect of frequently prescribed doses of vitamin D3 on longitudinal 25-OH-D concentrations, adjusting for obesity, season, and other factors. We conducted a cohort study (Instituto Nacional de Perinatología-INPer) (2017-2020)) of healthy pregnant women without complications. Pregestational overweight/obesity (body mass index ≥ 25), vitamin D3 supplementation (prescribed by physician; 0-250, 250-400, and >400 IU/day), and serum 25-OH-D concentrations (ELISA) were evaluated in each trimester of pregnancy. Vitamin D deficiency or insufficiency was computed (<20 and <30 ng/mL, respectively). We studied 141 adult women; 58.5% had pregestational obesity or overweight. In the first trimester, 45.8% of the women were supplemented with vitamin D3; 51.4% had vitamin D insufficiency and 37.3%, deficiency. In the third trimester, 75.4% of the women were supplemented, and 20% of them still had deficiency. The final general mixed linear model showed that 25-OH-D significantly increased throughout pregnancy ( p < 0.001); the highest increase was observed in the third trimester in women with doses >400 IU/day of vitamin D3 (+4 ng/mL, 95% CI: 1.72-8.11 ng/mL). In winter/autumn, 25-OH-D concentrations were also lower ( p ≤ 0.05). In this group of pregnant Mexican women, the prevalence of vitamin D deficiency and insufficiency was high. A higher increase in 25-OH-D concentrations during pregnancy was observed when the women were supplemented with >400 IU/day. Common supplementation doses of 250-400 IU/day were insufficient for achieving an adequate maternal vitamin D status.
- Published
- 2020
- Full Text
- View/download PDF
45. 25-Hydroxyvitamin D level, vitamin D intake, and risk of stroke: A dose-response meta-analysis.
- Author
-
Shi H, Chen H, Zhang Y, Li J, Fu K, Xue W, Teng W, and Tian L
- Subjects
- Adult, Aged, Biomarkers blood, Dose-Response Relationship, Drug, Female, Humans, Incidence, Male, Middle Aged, Protective Factors, Risk Assessment, Risk Factors, Stroke epidemiology, Treatment Outcome, Vitamin D adverse effects, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Dietary Supplements adverse effects, Stroke prevention & control, Vitamin D analogs & derivatives, Vitamin D therapeutic use, Vitamin D Deficiency drug therapy
- Abstract
Background & Aims: A growing number of studies have shown that vitamin D are related to the risk of stroke, however, the dose-response association between vitamin D and the risk of stroke is still unclear. Accordingly, we conducted a dose-response meta-analysis to evaluate the relationships between 25-hydroxyvitamin D [25(OH)D] level, vitamin D intake, and the risk of stroke by summarizing cohort studies., Methods: PubMed, Embase, Cochrane and the Web of Science database were searched for related studies. Cohort studies examining the influence of 25(OH)D level and vitamin D intake on stroke risk were summarized. Dose-response relationships were determined using a random-effect model., Results: Twenty cohort studies involving 217,235 participants were included. The pooled relative risk for the high-versus-low categories was 0.74 (95% CI: 0.66-0.83) for 25(OH)D level, and 0.75 (95% CI: 0.57-0.98) for vitamin D intake. In addition, there were non-linear relationships between 25(OH)D level, vitamin D intake, and stroke risk. The incidence of stroke was reduced to its lowest point, with a reduction of about 20%, when 25(OH)D level was about 50 nmol/L or vitamin D intake was about 12 μg/day., Conclusion: 25(OH)D level and vitamin D intake were both inversely related to stroke risk, with a non-linear dose-response relationship., (Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
46. Adherence to Vitamin D Intake Guidelines in the United States.
- Author
-
Simon AE and Ahrens KA
- Subjects
- Breast Feeding methods, Breast Feeding trends, Cross-Sectional Studies, Female, Humans, Infant, Infant Nutritional Physiological Phenomena physiology, Infant, Newborn, Male, Nutrition Surveys methods, Nutrition Surveys trends, United States epidemiology, Vitamin D Deficiency epidemiology, Vitamin D Deficiency prevention & control, Dietary Supplements, Infant Nutritional Physiological Phenomena drug effects, Medication Adherence, Nutrition Policy trends, Vitamin D administration & dosage
- Abstract
Background: The American Academy of Pediatrics (AAP) revised its infant vitamin D intake guidelines in 2008. We aimed to examine previously unexplored trends in meeting vitamin D intake guidelines among US infants since 2009 and whether there were differences across demographic subgroups., Methods: We analyzed dietary recall data for infants 0 to 11 months in the 2009-2016 NHANES. We estimated the percentage meeting 2008 AAP vitamin D guidelines, defined as consuming ≥1 L of infant formula and/or receiving a vitamin D supplement of ≥400 IU. We used Poisson regressions to assess trends over time and differences across demographic subgroups., Results: Overall, 27.1% (95% confidence interval [CI]: 24.3%-29.8%) of US infants in 2009-2016 met vitamin D intake guidelines, with nonbreastfeeding infants (31.1% [95% CI: 27.6%-34.5%]) more likely to meet guidelines than breastfeeding infants (20.5% [95% CI: 15.4%-25.5%]; P < .01). From 2009-2010 to 2015-2016, overall and for both breastfeeding and nonbreastfeeding infants, there were no significant changes over time in the percentage of infants who met the guidelines ( P > .05). Among breastfeeding infants, those with a family income ≥400% of the federal poverty level, with a college graduate head of household, and with private insurance were more likely to meet guidelines., Conclusions: Among US infants, we observed no increase in meeting AAP vitamin D intake guidelines since 2009. Less than 40% of infants met guidelines in nearly all demographic subgroups. These findings suggest renewed consideration of how to best meet vitamin D intake guidelines., Competing Interests: POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose., (Copyright © 2020 by the American Academy of Pediatrics.)
- Published
- 2020
- Full Text
- View/download PDF
47. Future perspectives in addressing the global issue of vitamin D deficiency.
- Author
-
Mendes MM, Charlton K, Thakur S, Ribeiro H, and Lanham-New SA
- Subjects
- Biological Variation, Population, Global Health, Humans, Nutritional Status, Recommended Dietary Allowances, Vitamin D analogs & derivatives, Vitamin D blood, Vitamin D Deficiency diagnosis, Dietary Supplements, Vitamin D administration & dosage, Vitamin D physiology, Vitamin D Deficiency epidemiology
- Abstract
Vitamin D is a fundamentally critical nutrient that the human body requires to function properly. It plays an important role in musculoskeletal health due to its involvement in the regulation of calcium and phosphorus. Having a low level of vitamin D in the body may be detrimental for a wide range of health outcomes, including risk of osteoporotic and stress fractures, risk of CVD and some cancers, and lowering of the capability of the immune system. Vitamin D is an unusual nutrient; it is not a vitamin, in the true sense of the word but a pro-hormone. The main source of vitamin D is UV exposure, not dietary intake. Interestingly, there are two forms of vitamin D, vitamin D2 and vitamin D3, both of which are metabolised into 25-hydroxyvitamin D (25(OH)D) in the liver, the biomarker of vitamin D status. Vitamin D deficiency is a global public health problem, especially amongst older people and ethnic minority groups. The newest publication from the UK Government's Public Health England Department recommends that vitamin D intake should be 10 μg daily and this recommendation compares well (albeit lower) with other guidelines such as the Institute of Medicine recommendation of 15 μg for those aged 1-70 years and 20 μg for those 70 years or over. Few countries, however, have a specific vitamin D policy to prevent deficiency in populations. Finland leads the way, demonstrating impressive results in reducing population-level vitamin D deficiency through mandatory food fortification programmes. Collaboration between academia, government and industry, including countries from varying latitudes, is essential to identify long-term solutions to the global issue of vitamin D deficiency. This paper provides a narrative review of the evidence related to the role of vitamin D deficiency in health outcomes, outlines controversies regarding setting levels of adequacy, identifies the prevalence of vitamin D deficiency across the globe, and identifies population-level strategies adopted by countries to prevent vitamin D deficiency.
- Published
- 2020
- Full Text
- View/download PDF
48. Safety of High-Dose Vitamin D Supplementation: Secondary Analysis of a Randomized Controlled Trial.
- Author
-
Billington EO, Burt LA, Rose MS, Davison EM, Gaudet S, Kan M, Boyd SK, and Hanley DA
- Subjects
- Aged, Calcium blood, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Pilot Projects, Prognosis, Vitamin D administration & dosage, Vitamin D blood, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Biomarkers blood, Dietary Supplements, Vitamin D analogs & derivatives, Vitamin D Deficiency prevention & control
- Abstract
Context: More than 3% of adults report vitamin D intakes of 4000 IU/day or more, but the safety of this practice is unknown., Objective: The objective of this work is to establish whether vitamin D doses up to 10 000 IU/day are safe and well tolerated., Design: The Calgary Vitamin D Study was a 3-year, double-blind, randomized controlled trial., Setting: A single-center study was conducted at the University of Calgary, Canada., Participants: Participants included healthy adults (n = 373) ages 55 to 70 years with serum 25-hydroxyvitamin D 30 to 125 nmol/L., Interventions: Participants were randomly assigned 1:1:1 to vitamin D3 400, 4 000, or 10 000 IU/day. Calcium supplementation was initiated if dietary calcium intake was less than 1200 mg/day., Main Outcome Measures: In these prespecified secondary analyses, changes in serum 25-hydroxyvitamin D, calcium, creatinine, 24-hour urine calcium excretion, and incidence of adverse events were assessed. Between-group differences in adverse events were examined using incident rate differences and logistic regression., Results: Of 373 participants (400: 124, 4000: 125, 10 000: 124), 49% were male, mean (SD) age was 64 (4) years, and 25-hydroxyvitamin D 78.0 (19.5) nmol/L. Serum calcium, creatinine, and 24-hour urine calcium excretion did not differ between treatments. Mild hypercalcemia (2.56-2.64 mmol/L) occurred in 15 (4%) participants (400: 0%, 4000: 3%, 10 000: 9%, P = .002); all cases resolved on repeat testing. Hypercalciuria occurred in 87 (23%) participants (400: 17%, 4000: 22%, 10 000: 31%, P = .01). Clinical adverse events were experienced by 365 (97.9%) participants and were balanced across treatment arms., Conclusions: The safety profile of vitamin D supplementation is similar for doses of 400, 4000, and 10 000 IU/day. Hypercalciuria was common and occurred more frequently with higher doses. Hypercalcemia occurred more frequently with higher doses but was rare, mild, and transient., (© Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
49. Vitamin D: can the sun stop the atopic epidemic?
- Author
-
Hawrylowicz CM and Santos AF
- Subjects
- Asthma blood, Asthma epidemiology, Asthma immunology, Biological Availability, Clinical Trials as Topic, Epidemics prevention & control, Female, Food Hypersensitivity blood, Food Hypersensitivity epidemiology, Food Hypersensitivity immunology, Gastrointestinal Microbiome immunology, Global Burden of Disease, Humans, Incidence, Intestinal Mucosa immunology, Intestinal Mucosa metabolism, Intestinal Mucosa microbiology, Maternal-Fetal Exchange, Perinatal Care methods, Permeability, Postnatal Care methods, Pregnancy, Treatment Outcome, Vitamin D blood, Vitamin D metabolism, Vitamin D Deficiency diet therapy, Vitamin D Deficiency epidemiology, Vitamin D Deficiency immunology, Asthma prevention & control, Dietary Supplements, Food Hypersensitivity prevention & control, Vitamin D administration & dosage, Vitamin D Deficiency complications
- Abstract
Purpose of Review: To review recent evidence on the capacity of vitamin D to prevent atopic disease, focussing on food allergy and asthma, and potential underlying mechanisms., Recent Findings: The incidence of allergic disease continues to increase worldwide. Vitamin D status is influenced by sun exposure and dietary intake. Vitamin D deficiency is linked to an increased incidence of allergic disease and asthma. These associations are generally strongest in early life. The capacity of vitamin D to enhance antimicrobial pathways, promote peripheral immunological tolerance and maintain mucosal barrier integrity may underlie these associations. Interventional studies have addressed the capacity of vitamin D supplementation in utero and early life to reduce the incidence of disease. Ancillary studies have provided insights into potential biological mechanisms linked to these effects., Summary: Observational studies show an inverse association between vitamin D levels and development of food allergy and asthma. Secondary analyses of two recent interventional studies suggest that achieving vitamin D sufficiency throughout pregnancy reduces the incidence of asthma/recurrent wheeze at 3 years. Longitudinal studies of vitamin D requirements in utero and postnatally, better understanding of factors that influence bioavailability of vitamin D and mechanistic insights into vitamin D effects on neonatal-specific immune pathways are awaited.
- Published
- 2020
- Full Text
- View/download PDF
50. Vitamin D Status in Japanese Adults: Relationship of Serum 25-Hydroxyvitamin D with Simultaneously Measured Dietary Vitamin D Intake and Ultraviolet Ray Exposure.
- Author
-
Asakura K, Etoh N, Imamura H, Michikawa T, Nakamura T, Takeda Y, Mori S, and Nishiwaki Y
- Subjects
- Adult, Aged, Biomarkers, Female, Humans, Japan epidemiology, Male, Middle Aged, Nutritional Status, Public Health Surveillance, Sunlight, Vitamin D administration & dosage, Vitamin D Deficiency blood, Vitamin D Deficiency epidemiology, Vitamin D Deficiency etiology, Young Adult, Dietary Supplements, Ultraviolet Rays, Vitamin D analogs & derivatives, Vitamin D blood
- Abstract
Vitamin D insufficiency/deficiency is prevalent worldwide. We investigated the effect of vitamin D intake and ultraviolet ray (UV) exposure on serum vitamin D concentration in Japan. A total of 107 healthy adult participants were recruited from Hokkaido (43°N) and Kumamoto (33°N) prefectures. All participants undertook surveys in both summer and winter. Serum 25-hydroxyvitamin D (25(OH)D
3 ) was examined, and vitamin D intake was assessed with a diet history questionnaire. UV exposure was measured with a wearable UV dosimeter. Regression analysis was performed to investigate the relationship between these factors, with covariates such as sun avoidance behavior. The prevalence of vitamin D insufficiency (serum 25(OH)D3 ; 12 ng/ml (30 nmol/L) ≤ and <20 ng/ml (50 nmol/L))/deficiency (<12 ng/ml) was 47.7% in summer and 82.2% in winter. UV exposure time was short in Kumamoto (the urban area), at 11.6 minutes in summer and 14.9 minutes in winter. In Hokkaido (the rural area), UV exposure time was 58.3 minutes in summer and 22.5 minutes in winter. Vitamin D intake was significantly associated with serum 25(OH)D3 , and a 1 μg/1000kcal increase in intake was necessary to increase 25(OH)D3 by 0.88 ng/ml in summer and by 1.7 ng/ml in winter. UV exposure time was significantly associated with serum 25(OH)D3 in summer, and a 10 min increase in UV exposure time was necessary to increase 25(OH)D3 by 0.47 ng/ml. Although consideration of personal occupation and lifestyle is necessary, most Japanese may need to increase both vitamin D intake and UV exposure.- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.